Pharmacovigilance Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Feb 2022| TMR2668A| Transparency

Report Highlights

Pharmacovigilance Market – Scope of Report

TMR’s report on the global pharmacovigilance market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global pharmacovigilance market for the period 2017–2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global pharmacovigilance market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ literature, annual reports, press releases, and relevant documents to understand the global pharmacovigilance market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global pharmacovigilance market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global pharmacovigilance market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global pharmacovigilance market.

The report delves into the competition landscape of the global pharmacovigilance market. Key players operating in the global pharmacovigilance market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global pharmacovigilance market that have been profiled in this report.

Key Questions Answered in Pharmacovigilance Market Report

  • What is the scope of growth of phase of drug development companies in the global pharmacovigilance market?
  • What will be the Y-o-Y growth of the global pharmacovigilance market between 2019 and 2027?
  • What is the influence of changing trends in technologies on the global pharmacovigilance market?
  • Which region is likely to be the most profitable market for pharmacovigilance?
  • Which factors are anticipated to hamper the growth of the global pharmacovigilance market during the forecast period?
  • Which are the leading companies in the global pharmacovigilance market?

Frequently Asked Questions (FAQs)

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global pharmacovigilance market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global pharmacovigilance market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the pharmacovigilance market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the pharmacovigilance market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global pharmacovigilance market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global pharmacovigilance market more reliably and accurately.

  • Table 1 : Global Pharmacovigilance Market Size (US$ Mn) Forecast, by Phase of Drug Development, 2017–2028
  • Table 2 : Global Pharmacovigilance Market Size (US$ Mn) Forecast, by Type of Method, 2017–2028
  • Table 3 : Global Pharmacovigilance Market Size (US$ Mn) Forecast, by Type of Service, 2017–2028
  • Table 4 : Global Pharmacovigilance Market Size (US$ Mn) Forecast, by Region, 2017–2028
  • Table 5 : North America Pharmacovigilance Market Size (US$ Mn) Forecast, by Phase of Drug Development, 2017–2028
  • Table 6 : North America Pharmacovigilance Market Size (US$ Mn) Forecast, by Type of Method, 2017–2028
  • Table 7 : North America Pharmacovigilance Market Size (US$ Mn) Forecast, by Type of Service, 2017–2028
  • Table 8 : North America Pharmacovigilance Market Size (US$ Mn) Forecast, by Country, 2017–2028
  • Table 9 : Europe Pharmacovigilance Market Size (US$ Mn) Forecast, by Phase of Drug Development, 2017–2028
  • Table 10 : Europe Pharmacovigilance Market Size (US$ Mn) Forecast, by Type of Method, 2017–2028
  • Table 11 : Europe Pharmacovigilance Market Size (US$ Mn) Forecast, by Type of Service, 2017–2028
  • Table 12 : Europe Pharmacovigilance Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
  • Table 13 : Asia Pacific Pharmacovigilance Market Size (US$ Mn) Forecast, by Phase of Drug Development, 2017–2028
  • Table 14 : Asia Pacific Pharmacovigilance Market Size (US$ Mn) Forecast, by Type of Method, 2017–2028
  • Table 15 : Asia Pacific Pharmacovigilance Market Size (US$ Mn) Forecast, by Type of Service, 2017–2028
  • Table 16 : Asia Pacific Pharmacovigilance Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
  • Table 17 : Latin America Pharmacovigilance Market Size (US$ Mn) Forecast, by Phase of Drug Development, 2017–2028
  • Table 18 : Latin America Pharmacovigilance Market Size (US$ Mn) Forecast, by Type of Method, 2017–2028
  • Table 19 : Latin America Pharmacovigilance Market Size (US$ Mn) Forecast, by Type of Service, 2017–2028
  • Table 20 : Latin America Pharmacovigilance Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
  • Table 21 : Middle East & Africa Pharmacovigilance Market Size (US$ Mn) Forecast, by Phase of Drug Development, 2017–2028
  • Table 22 : Middle East & Africa Pharmacovigilance Market Size (US$ Mn) Forecast, by Type of Method, 2017–2028
  • Table 23 : Middle East & Africa Pharmacovigilance Market Size (US$ Mn) Forecast, by Type of Service, 2017–2028
  • Table 24 : Middle East & Africa Pharmacovigilance Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2028
  • Figure 1 : Pharmacovigilance Market Snapshot
  • Figure 2 : Global Pharmacovigilance Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2027
  • Figure 3 : Market Value Share, by Phase of Drug Development, 2018
  • Figure 4 : Market Value Share, by Type of Service, 2018
  • Figure 5 : Market Value Share, by Region, 2018
  • Figure 6 : Global Pharmacovigilance Market Value Share Analysis, by Phase of Drug Development, 2020 and 2028
  • Figure 7 : Global Pharmacovigilance Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Preclinical Studies, 2017–2028
  • Figure 8 : Global Pharmacovigilance Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Phase I, 2017–2028
  • Figure 9 : Global Pharmacovigilance Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Phase II, 2017–2028
  • Figure 10 : Global Pharmacovigilance Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Phase III, 2017–2028
  • Figure 11 : Global Pharmacovigilance Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Phase IV or Post Marketing Surveillance, 2017–2028
  • Figure 12 : Global Pharmacovigilance Market Attractiveness Analysis, 2021-2028, by Phase of Drug Development
  • Figure 13 : Global Pharmacovigilance Market Value Share Analysis, by Type of Method, 2020 and 2028
  • Figure 14 : Global Pharmacovigilance Market Revenue (US$ Mn) and Y-o-Y Growth (%), Spontaneous Reporting, 2017–2028
  • Figure 15 : Global Pharmacovigilance Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Intensified ADR Reporting, 2017–2028
  • Figure 16 : Global Pharmacovigilance Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Targeted Spontaneous Reporting, 2017–2028
  • Figure 17 : Global Pharmacovigilance Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cohort Event Monitoring, 2017–2028
  • Figure 18 : Global Pharmacovigilance Market Revenue (US$ Mn) and Y-o-Y Growth (%), by EHR Mining, 2017–2028
  • Figure 19 : Global Pharmacovigilance Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2028
  • Figure 20 : Global Pharmacovigilance Market Attractiveness Analysis, by Type of Method, 2021-2028
  • Figure 21 : Global Pharmacovigilance Market Value Share Analysis, by Type of Service Providers, 2020 and 2028
  • Figure 22 : Global Pharmacovigilance Market Revenue (US$ Mn) and Y-o-Y Growth (%), by In-house, 2017–2028
  • Figure 23 : Global Pharmacovigilance Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Outsourcing, 2017–2028
  • Figure 24 : Global Pharmacovigilance Market Attractiveness Analysis, by Type of Service, 2021-2028
  • Figure 25 : Global Pharmacovigilance Market Value Share Analysis, by Region, 2020 and 2028
  • Figure 26 : Global Pharmacovigilance Market Attractiveness Analysis, by Region, 2021-2028
  • Figure 27 : North America Pharmacovigilance Market Size (US$ Mn) Forecast, 2017–2028
  • Figure 28 : North America Pharmacovigilance Market Attractiveness Analysis, by Country, 2021-2028
  • Figure 29 : North America Pharmacovigilance Market Value Share Analysis, by Phase of Drug Development, 2020 and 2028
  • Figure 30 : North America Pharmacovigilance Market Value Share Analysis, by Type of Method, 2020 and 2028
  • Figure 31 : North America Pharmacovigilance Market Value Share Analysis, by Type of Service, 2020 and 2028
  • Figure 32 : North America Pharmacovigilance Market Value Share Analysis, by Country, 2020 and 2028
  • Figure 33 : North America Pharmacovigilance Market Attractiveness Analysis, by Phase of Drug Development, 2021-2028
  • Figure 34 : North America Pharmacovigilance Market Attractiveness Analysis, by Type of Method, 2021-2028
  • Figure 35 : North America Pharmacovigilance Market Attractiveness Analysis, by Type of Service, 2021-2028
  • Figure 36 : Europe Pharmacovigilance Market Size (US$ Mn) Forecast, 2017–2028
  • Figure 37 : Europe Pharmacovigilance Market Attractiveness Analysis, by Country, 2021-2028
  • Figure 38 : Europe Pharmacovigilance Market Value Share Analysis, by Phase of Drug Development, 2020 and 2028
  • Figure 39 : Europe Pharmacovigilance Market Value Share Analysis, by Type of Method, 2020 and 2028
  • Figure 40 : Europe Pharmacovigilance Market Value Share Analysis, by Type of Service, 2020 and 2028
  • Figure 41 : Europe Pharmacovigilance Market Value Share Analysis, by Country, 2020 and 2028
  • Figure 42 : Europe Pharmacovigilance Market Attractiveness Analysis, by Phase of Drug Development, 2021-2028
  • Figure 43 : Europe Pharmacovigilance Market Attractiveness Analysis, by Type of Method, 2021-2028
  • Figure 44 : Europe Pharmacovigilance Market Attractiveness Analysis, by Type of Service, 2021-2028
  • Figure 45 : Asia Pacific Pharmacovigilance Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017– 2028
  • Figure 46 : Asia Pacific Pharmacovigilance Market Attractiveness Analysis, by Country 2021–2028
  • Figure 47 : Asia Pacific Pharmacovigilance Market Value Share Analysis, by Phase of Drug Development, 2020 and 2028
  • Figure 48 : Asia Pacific Pharmacovigilance Market Value Share Analysis, by Type of Method, 2020 and 2028
  • Figure 49 : Asia Pacific Pharmacovigilance Market Value Share Analysis, by Type of Service, 2020 and 2028
  • Figure 50 : Asia Pacific Pharmacovigilance Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 51 : Asia Pacific Pharmacovigilance Market Attractiveness Analysis, by Phase of Drug Development, 2021-2028
  • Figure 52 : Asia Pacific Pharmacovigilance Market Attractiveness Analysis, by Type of Method, 2021-2028
  • Figure 53 : Asia Pacific Pharmacovigilance Market Attractiveness Analysis, by Type of Service, 2021-2028
  • Figure 54 : Latin America Pharmacovigilance Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028
  • Figure 55 : Latin America Pharmacovigilance Market Attractiveness Analysis, 2021-2028, by Country/Sub-region, 2021–2028
  • Figure 56 : Latin America Pharmacovigilance Market Value Share Analysis, by Phase of Drug Development, 2020 and 2028
  • Figure 57 : Latin America Pharmacovigilance Market Value Share Analysis, by Type of Method, 2020 and 2028
  • Figure 58 : Latin America Pharmacovigilance Market Value Share Analysis, by Type of Service, 2020 and 2028
  • Figure 59 : Latin America Pharmacovigilance Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
  • Figure 60 : Latin America Pharmacovigilance Market Attractiveness Analysis, by Phase of Drug Development, 2021-2028
  • Figure 61 : Latin America Pharmacovigilance Market Attractiveness Analysis, by Type of Method, 2021-2028
  • Figure 62 : Latin America Pharmacovigilance Market Attractiveness Analysis, by Type of Service, 2021-2028
  • Figure 63 : Middle East & Africa Pharmacovigilance Market Size (US$ Mn) Forecast, 2017–2028
  • Figure 64 : Middle East & Africa Pharmacovigilance Market Attractiveness Analysis, by Country/Sub-region, 2021-2028
  • Figure 65 : Middle East & Africa Pharmacovigilance Market Value Share Analysis, by Phase of Drug Development, 2020 and 2028
  • Figure 66 : Middle East & Africa Pharmacovigilance Market Value Share Analysis, by Type of Method, 2020 and 2028
  • Figure 67 : Middle East & Africa Pharmacovigilance Market Value Share Analysis, by Type of Service, 2020 and 2028
  • Figure 68 : Middle East & Africa Pharmacovigilance Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
  • Figure 69 : Middle East & Africa Pharmacovigilance Market Attractiveness Analysis, by Phase of Drug Development, 2021-2028
  • Figure 70 : Middle East & Africa Pharmacovigilance Market Attractiveness Analysis, by Type of Method, 2021-2028
  • Figure 71 : Middle East & Africa Pharmacovigilance Market Attractiveness Analysis, by Type of Service, 2021-2028
  • Figure 72 : Global Pharmacovigilance Market Share Analysis, by Company (2020)

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Transparency
Price: $5795

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS